Pegasys Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials

HELPS Study - A Study of Peginterferon Alfa-2a (Pegasys) in Patients With Chronic Hepatitis C (CHC) and End-Stage Renal Disease (ESRD)
Condition:   Hepatitis C, ChronicIntervention:   Drug: Peginterferon alfa-2aSponsor:   Hoffmann-La RocheCompleted - verified June 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 16, 2016 Category: Research Source Type: clinical trials

A Study of Peginterferon Alfa-2a Plus Ribavirin in Early Non-Responder Participants With Chronic Hepatitis C (CHC) Genotype 1, 4, 5, and 6
Condition:   Hepatitis C, ChronicInterventions:   Drug: Ribavirin;   Drug: peginterferon alfa-2aSponsor:   Hoffmann-La RocheCompleted - verified June 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 31, 2016 Category: Research Source Type: clinical trials

A Study of Peginterferon Alfa-2a in Participants With Chronic Hepatitis B Virus (HBV) in an Expanded Access Program
Condition:   Hepatitis B, ChronicIntervention:   Drug: Peginterferon alfa-2aSponsor:   Hoffmann-La RocheAvailable - verified June 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 31, 2016 Category: Research Source Type: clinical trials